MyLynch, a patient-facing clinical decision support(CDS) web application that applies genetically-guided personalised medicine(GPM) for individuals with Lynch syndrome.
As genetic panel testing becomes more widely available, GPM will play an increasingly important role in patient care, and CDS tools offer patients and providers tailored information to inform decision-making.
MyLynch provides personalised cancer risk estimates and interventions to lower these risks for patients with LS.
Lynch Syndrome Ireland 